EUVIMEDEUVIMED entdecken
Crossref

Robotic-assisted soft-tissue pelvic exenteration for primary and recurrent pelvic tumours: IDEAL stage 2a evaluation

Christina A Fleming iD, Deena Harji iD, Cécile Salut, Thomas Cauvin, Grégoire Robert, Quentin Denost

British Journal of Surgery · 2023

DOI: 10.1093/bjs/znac422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Surgery, 2023. Verfasst von Christina A Fleming und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, CHU, Bordeaux, France. Hauptthemen laut MEDLINE: Pelvic Exenteration, Pelvic Neoplasms, Robotic Surgical Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pelvic exenteration (PE) can cure advanced cases of locally advanced primary and recurrent pelvic cancers1–3. Outcomes following PE are optimized when managed by high-volume multidisciplinary teams2–4. Currently, most PE procedures are performed by open surgery with severe surgical morbidity reported in up to 60 per cent of cases2,3. Minimally invasive surgery (MIS) has numerous benefits in abdominopelvic surgery, including reduced blood loss, reduced morbidity, and reduced duration of hospital stay5,6. The application of minimally invasive PE has been limited owing to the anatomical limitations of the bony pelvis; however, robotic surgery platforms can overcome many of these challenges. In 2018, a systematic review comparing open and minimally invasive PE reporting on 170 patients demonstrated that MIS-PE was associated with reduced intraoperative blood loss, reduced morbidity, and shorter duration of hospital stay7. Reports of robotic PE are limited8 to single-centre case series and video vignettes from high-volume centres9–12. To progress robotic PE, it is important to standardize and refine operative techniques, further understand operative and oncological outcomes, and define training requirements and core outcome measures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pelvic ExenterationPelvic NeoplasmsRobotic Surgical ProceduresHumansNeoplasm Recurrence, LocalPelvisRetrospective Studies

Autor:innen und Institutionen

  • Department of Colorectal Surgery, CHU, Bordeaux, France.
  • Department of Radiology, CHU, Bordeaux, France.
  • Department of Urology, CHU, Bordeaux, France.
  • Bordeaux Colorectal Institute, Clinique Tivoli, Bordeaux, France.

ORCID-Profile: Christina A Fleming, Deena Harji

Zitieren

APA

Fleming, C. A., Harji, D., Salut, C., Cauvin, T., Robert, G., & Denost, Q. (2023). Robotic-assisted soft-tissue pelvic exenteration for primary and recurrent pelvic tumours: IDEAL stage 2a evaluation. British Journal of Surgery. https://doi.org/10.1093/bjs/znac422

Vancouver

Fleming CA, Harji D, Salut C, Cauvin T, Robert G, Denost Q. Robotic-assisted soft-tissue pelvic exenteration for primary and recurrent pelvic tumours: IDEAL stage 2a evaluation. British Journal of Surgery. 2023. doi:10.1093/bjs/znac422

BibTeX
@article{Fleming2023,
  author = {Fleming, Christina A and Harji, Deena and Salut, Cécile and Cauvin, Thomas and Robert, Grégoire and Denost, Quentin},
  title = {Robotic-assisted soft-tissue pelvic exenteration for primary and recurrent pelvic tumours: IDEAL stage 2a evaluation},
  journal = {British Journal of Surgery},
  year = {2023},
  doi = {10.1093/bjs/znac422}
}
Kostenlos starten →